
Peter Tyrer
REFERENCE: Lancet 371:57 January 5, 2008
PETER TYRER, Imperial College, W6 8RP London
A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as
PETER TYRER, Imperial College, W6 8RP London
A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as
…








Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI+
5th November 2007
Laura Mauri
Raymond Gibbons
LAURA MAURI, Brigham and Woman’s Hospital, Boston Massachusetts
COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester, Minnesota
The largest study to date looking
…